Correlation Between Ensysce Biosciences and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ensysce Biosciences and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ensysce Biosciences and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ensysce Biosciences and Carmell Therapeutics, you can compare the effects of market volatilities on Ensysce Biosciences and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ensysce Biosciences with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ensysce Biosciences and Carmell Therapeutics.
Diversification Opportunities for Ensysce Biosciences and Carmell Therapeutics
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Ensysce and Carmell is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Ensysce Biosciences and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Ensysce Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ensysce Biosciences are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Ensysce Biosciences i.e., Ensysce Biosciences and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Ensysce Biosciences and Carmell Therapeutics
Given the investment horizon of 90 days Ensysce Biosciences is expected to generate 1.53 times more return on investment than Carmell Therapeutics. However, Ensysce Biosciences is 1.53 times more volatile than Carmell Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 57.00 in Ensysce Biosciences on September 2, 2024 and sell it today you would lose (8.00) from holding Ensysce Biosciences or give up 14.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ensysce Biosciences vs. Carmell Therapeutics
Performance |
| Timeline |
| Ensysce Biosciences |
| Carmell Therapeutics |
Ensysce Biosciences and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ensysce Biosciences and Carmell Therapeutics
The main advantage of trading using opposite Ensysce Biosciences and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ensysce Biosciences position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| Ensysce Biosciences vs. Tff Pharmaceuticals | Ensysce Biosciences vs. Eliem Therapeutics | Ensysce Biosciences vs. Inhibrx | Ensysce Biosciences vs. Enliven Therapeutics |
| Carmell Therapeutics vs. Western Acquisition Ventures | Carmell Therapeutics vs. Bill Com Holdings | Carmell Therapeutics vs. Equinix | Carmell Therapeutics vs. Rumble Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |